The identification of GPR3 inverse agonist AF64394; the first small molecule inhibitor of GPR3 receptor function
- Bioorg Med Chem Lett. 2014 Nov 15;24(22):5195-8. doi: 10.1016/j.bmcl.2014.09.077.
- 1. Neuroscience Drug Discovery, H-Lundbeck A/S, 2500 Valby, Copenhagen, Denmark.
The identification of the novel and selective GPR3 inverse agonist AF64394, the first small molecule inhibitor of GPR3 receptor function, is described. Structure activity relationships and syntheses based around AF64394 are reported.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Orphan GPCRResearch Areas: Others